The prenatal origins of cancer (original) (raw)

• Valent, P. et al. Cancer stem cell definitions and terminology: the devil is in the details. Nat. Rev. Cancer 12, 767–775 (2012).
  CAS PubMed Google Scholar
• Greaves, M. F., Maia, A. T., Wiemels, J. L. & Ford, A. M. Leukemia in twins: lessons in natural history. Blood 102, 2321–2333 (2003).
  CAS PubMed Google Scholar
• Eaton, K. W., Tooke, L. S., Wainwright, L. M., Judkins, A. R. & Biegel, J. A. Spectrum of SMARCB1/INI1 mutations in familial and sporadic rhabdoid tumors. Pediatr. Blood Cancer 56, 7–15 (2011).
  PubMed PubMed Central Google Scholar
• Nuchtern, J. G. et al. A prospective study of expectant observation as primary therapy for neuroblastoma in young infants: a Children's Oncology Group study. Ann. Surg. 256, 573–580 (2012).
  PubMed Google Scholar
• Beckwith, J. B. Precursor lesions of Wilms tumor: clinical and biological implications. Med. Pediatr. Oncol. 21, 158–168 (1993).
  CAS PubMed Google Scholar
• Cohnheim, J. Congenitales, quergestreiftes Muskelsarkom der Nieren. Virchows Archiv 65, 64–69 (in German) (1875).
  Google Scholar
• Durante, F. Nesso fisio-patologico tra la struttura dei nei materni e la genesi di alcuni tumori maligni. Arch. Memo. Observ. Chir Prat 11, 217–226 (in Italian) (1874).
  Google Scholar
• Virchow, R. Die multiloculäre, ulcerirende Echinokokkengeschwulst der Leber. Verhandlungen der Physicalisch-Medicinischen Gesellschaft, 6, 84–95 (in German) (1855).
  Google Scholar
• Gruhn, B. et al. Prenatal origin of childhood acute lymphoblastic leukemia, association with birth weight and hyperdiploidy. Leukemia 22, 1692–1697 (2008).
  CAS PubMed Google Scholar
• Pine, S. R. et al. Incidence and clinical implications of GATA1 mutations in newborns with Down syndrome. Blood 110, 2128–2131 (2007).
  CAS PubMed Google Scholar
• Brodeur, G. M. Neuroblastoma: biological insights into a clinical enigma. Nat. Rev. Cancer 3, 203–216 (2003).
  CAS PubMed Google Scholar
• Maris, J. M. Recent advances in neuroblastoma. New Engl. J. Med. 362, 2202–2211 (2010).
  CAS PubMed Google Scholar
• Huber, K. The sympathoadrenal cell lineage: specification, diversification, and new perspectives. Dev. Biol. 298, 335–343 (2006).
  CAS PubMed Google Scholar
• Zimmerman, K. A. et al. Differential expression of myc family genes during murine development. Nature 319, 780–783 (1986).
  CAS PubMed Google Scholar
• Hansford, L. M. et al. Mechanisms of embryonal tumor initiation: distinct roles for MycN expression and MYCN amplification. Proc. Natl Acad. Sci. USA 101, 12664–12669 (2004).
  CAS PubMed PubMed Central Google Scholar
• Wartiovaara, K., Barnabe-Heider, F., Miller, F. D. & Kaplan, D. R. N-myc promotes survival and induces S-phase entry of postmitotic sympathetic neurons. J. Neurosci. 22, 815–824 (2002).
  CAS PubMed PubMed Central Google Scholar
• Yuan, J. & Yankner, B. A. Apoptosis in the nervous system. Nature 407, 802–809 (2000).
  CAS PubMed Google Scholar
• Zhu, S. et al. Activated ALK collaborates with MYCN in neuroblastoma pathogenesis. Cancer Cell 21, 362–373 (2012).
  CAS PubMed PubMed Central Google Scholar
• Calao, M. et al. Direct effects of Bmi1 on p53 protein stability inactivates oncoprotein stress responses in embryonal cancer precursor cells at tumor initiation. Oncogene 32, 3616–3626 (2013).
  CAS PubMed Google Scholar
• Weiss, W. A., Aldape, K., Mohapatra, G., Feuerstein, B. G. & Bishop, J. M. Targeted expression of MYCN causes neuroblastoma in transgenic mice. EMBO J. 16, 2985–2995 (1997).
  CAS PubMed PubMed Central Google Scholar
• Marshall, G. M. et al. SIRT1 promotes N-Myc oncogenesis through a positive feedback loop involving the effects of MKP3 and ERK on N-Myc protein stability. PLoS Genet. 7, e1002135 (2011).
  CAS PubMed PubMed Central Google Scholar
• Liu, P. Y. et al. The histone deacetylase SIRT2 stabilizes Myc oncoproteins. Cell Death Differ. 20, 503–514 (2013).
  CAS PubMed Google Scholar
• Murphy, D. J. et al. Distinct thresholds govern Myc's biological output in vivo. Cancer Cell 14, 447–457 (2008).
  CAS PubMed Google Scholar
• Berry, T. et al. The ALK F1174L mutation potentiates the oncogenic activity of MYCN in neuroblastoma. Cancer Cell 22, 117–130 (2012).
  CAS PubMed PubMed Central Google Scholar
• Reissmann, E. et al. Involvement of bone morphogenetic protein-4 and bone morphogenetic protein-7 in the differentiation of the adrenergic phenotype in developing sympathetic neurons. Development 122, 2079–2088 (1996).
  CAS PubMed Google Scholar
• Schneider, C., Wicht, H., Enderich, J., Wegner, M. & Rohrer, H. Bone morphogenetic proteins are required in vivo for the generation of sympathetic neurons. Neuron 24, 861–870 (1999).
  CAS PubMed Google Scholar
• Mosse, Y. P. et al. Germline PHOX2B mutation in hereditary neuroblastoma. Am. J. Hum. Genet. 75, 727–730 (2004).
  CAS PubMed PubMed Central Google Scholar
• Trochet, D. et al. Germline mutations of the paired-like homeobox 2B (PHOX2B) gene in neuroblastoma. Am. J. Hum. Genet. 74, 761–764 (2004).
  CAS PubMed PubMed Central Google Scholar
• Bourdeaut, F. et al. Germline mutations of the paired-like homeobox 2B (PHOX2B) gene in neuroblastoma. Cancer Lett. 228, 51–58 (2005).
  CAS PubMed Google Scholar
• Reiff, T. et al. Neuroblastoma phox2b variants stimulate proliferation and dedifferentiation of immature sympathetic neurons. J. Neurosci. 30, 905–915 (2010).
  CAS PubMed PubMed Central Google Scholar
• Alam, G. et al. MYCN promotes the expansion of Phox2B-positive neuronal progenitors to drive neuroblastoma development. Am. J. Pathol. 175, 856–866 (2009).
  CAS PubMed PubMed Central Google Scholar
• Rybak, A. et al. A feedback loop comprising lin-28 and let-7 controls pre-let-7 maturation during neural stem-cell commitment. Nature Cell Biol. 10, 987–993 (2008).
  CAS PubMed Google Scholar
• Molenaar, J. J. et al. LIN28B induces neuroblastoma and enhances MYCN levels via let-7 suppression. Nature Genet. 44, 1199–1206 (2012).
  CAS PubMed Google Scholar
• Yu, J. et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 318, 1917–1920 (2007).
  CAS PubMed Google Scholar
• Balzer, E., Heine, C., Jiang, Q., Lee, V. M. & Moss, E. G. LIN28 alters cell fate succession and acts independently of the let-7 microRNA during neurogliogenesis in vitro. Development 137, 891–900 (2010).
  CAS PubMed Google Scholar
• Murray, M. J. et al. LIN28 Expression in malignant germ cell tumors downregulates let-7 and increases oncogene levels. Cancer Res. 73, 4872–4884 (2013).
  CAS PubMed PubMed Central Google Scholar
• Reiff, T. et al. Midkine and Alk signaling in sympathetic neuron proliferation and neuroblastoma predisposition. Development 138, 4699–4708 (2011).
  CAS PubMed Google Scholar
• Cheng, L. Y. et al. Anaplastic lymphoma kinase spares organ growth during nutrient restriction in Drosophila. Cell 146, 435–447 (2011).
  CAS PubMed Google Scholar
• Mosse, Y. P. et al. Identification of ALK as a major familial neuroblastoma predisposition gene. Nature 455, 930–935 (2008).
  CAS PubMed PubMed Central Google Scholar
• Janoueix-Lerosey, I. et al. Somatic and germline activating mutations of the ALK kinase receptor in neuroblastoma. Nature 455, 967–970 (2008).
  CAS PubMed Google Scholar
• Chen, Y. Y. et al. Oncogenic mutations of ALK kinase in neuroblastoma. Nature 455, 971–974 (2008).
  CAS PubMed Google Scholar
• De Brouwer, S. et al. Meta-analysis of neuroblastomas reveals a skewed ALK mutation spectrum in tumors with MYCN amplification. Clin. Cancer Res. 16, 4353–4362 (2010).
  CAS PubMed Google Scholar
• Heukamp, L. C. et al. Targeted expression of mutated ALK induces neuroblastoma in transgenic mice. Sci. Transl. Med. 4, ra91 (2012).
  Google Scholar
• Schulte, J. H. et al. MYCN and ALKF1174L are sufficient to drive neuroblastoma development from neural crest progenitor cells. Oncogene 21, 1059–1065 (2012).
  Google Scholar
• De Preter, K. et al. Human fetal neuroblast and neuroblastoma transcriptome analysis confirms neuroblast origin and highlights neuroblastoma candidate genes. Genome Biol. 7, 17 (2006).
  Google Scholar
• Beckwith, J. B. & Perrin, E. V. In situ neuroblastomas: a contribution to the natural history of neural crest tumors. Am. J. Pathol. 43, 1089–1104 (1963).
  CAS PubMed PubMed Central Google Scholar
• Woods, W. G. et al. A population-based study of the usefulness of screening for neuroblastoma. Lancet 348, 1682–1687 (1996).
  CAS PubMed Google Scholar
• Murtaza, M. et al. Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA. Nature 497, 108–112 (2013).
  CAS PubMed Google Scholar
• Roy, A., Roberts, I., Norton, A. & Vyas, P. Acute megakaryoblastic leukaemia (AMKL) and transient myeloproliferative disorder (TMD) in Down syndrome: a multi-step model of myeloid leukaemogenesis. Br. J. Haematol. 147, 3–12 (2009).
  CAS PubMed Google Scholar
• Brodeur, G. M., Dahl, G. V., Williams, D. L., Tipton, R. E. & Kalwinsky, D. K. Transient leukemoid reaction and trisomy 21 mosaicism in a phenotypically normal newborn. Blood 55, 691–693 (1980).
  CAS PubMed Google Scholar
• Hasle, H. et al. A pediatric approach to the WHO classification of myelodysplastic and myeloproliferative diseases. Leukemia 17, 277–282 (2003).
  CAS PubMed Google Scholar
• Massey, G. V. et al. A prospective study of the natural history of transient leukemia (TL) in neonates with Down syndrome (DS): Children's Oncology Group (COG) study POG-9481. Blood 107, 4606–4613 (2006).
  CAS PubMed Google Scholar
• Klusmann, J. H. et al. Treatment and prognostic impact of transient leukemia in neonates with Down syndrome. Blood 111, 2991–2998 (2008).
  CAS PubMed PubMed Central Google Scholar
• Tunstall-Pedoe, O. et al. Abnormalities in the myeloid progenitor compartment in Down syndrome fetal liver precede acquisition of GATA1 mutations. Blood 112, 4507–4511 (2008).
  CAS PubMed Google Scholar
• Polski, J. M. et al. Acute megakaryoblastic leukemia after transient myeloproliferative disorder with clonal karyotype evolution in a phenotypically normal neonate. J. Pediatr. Hematol. Oncol. 24, 50–54 (2002).
  PubMed Google Scholar
• Maclean, G. A. et al. Altered hematopoiesis in trisomy 21 as revealed through in vitro differentiation of isogenic human pluripotent cells. Proc. Natl Acad. Sci. USA 109, 17567–17572 (2012).
  CAS PubMed PubMed Central Google Scholar
• Chou, S. T. et al. Trisomy 21-associated defects in human primitive hematopoiesis revealed through induced pluripotent stem cells. Proc. Natl Acad. Sci. USA 109, 17573–17578 (2012).
  CAS PubMed PubMed Central Google Scholar
• Kirsammer, G. et al. Highly penetrant myeloproliferative disease in the Ts65Dn mouse model of Down syndrome. Blood 111, 767–775 (2008).
  CAS PubMed PubMed Central Google Scholar
• Dore, L. C. & Crispino, J. D. Transcription factor networks in erythroid cell and megakaryocyte development. Blood 118, 231–239 (2011).
  CAS PubMed PubMed Central Google Scholar
• Bourquin, J. P. et al. Identification of distinct molecular phenotypes in acute megakaryoblastic leukemia by gene expression profiling. Proc. Natl Acad. Sci. USA 103, 3339–3344 (2006).
  CAS PubMed PubMed Central Google Scholar
• Stankiewicz, M. J. & Crispino, J. D. ETS2 and ERG promote megakaryopoiesis and synergize with alterations in GATA-1 to immortalize hematopoietic progenitor cells. Blood 113, 3337–3347 (2009).
  CAS PubMed PubMed Central Google Scholar
• Salek-Ardakani, S. et al. ERG is a megakaryocytic oncogene. Cancer Res. 69, 4665–4673 (2009).
  CAS PubMed Google Scholar
• Birger, Y. et al. Perturbation of fetal hematopoiesis in a mouse model of Down syndrome's transient myeloproliferative disorder. Blood 122, 988–998 (2013).
  CAS PubMed PubMed Central Google Scholar
• Elagib, K. E. et al. RUNX1 and GATA-1 coexpression and cooperation in megakaryocytic differentiation. Blood 101, 4333–4341 (2003).
  CAS PubMed Google Scholar
• Gurbuxani, S., Vyas, P. & Crispino, J. D. Recent insights into the mechanisms of myeloid leukemogenesis in Down syndrome. Blood 103, 399–406 (2004).
  CAS PubMed Google Scholar
• Taub, J. W. et al. Prenatal origin of GATA1 mutations may be an initiating step in the development of megakaryocytic leukemia in Down syndrome. Blood 104, 1588–1589 (2004).
  CAS PubMed Google Scholar
• Li, Z. et al. Developmental stage-selective effect of somatically mutated leukemogenic transcription factor GATA1. Nature Genet. 37, 613–619 (2005).
  CAS PubMed Google Scholar
• Hitzler, J. K., Cheung, J., Li, Y., Scherer, S. W. & Zipursky, A. GATA1 mutations in transient leukemia and acute megakaryoblastic leukemia of Down syndrome. Blood 101, 4301–4304 (2003).
  CAS PubMed Google Scholar
• Rainis, L. et al. Mutations in exon 2 of GATA1 are early events in megakaryocytic malignancies associated with trisomy 21. Blood 102, 981–986 (2003).
  CAS PubMed Google Scholar
• Alford, K. A. et al. Analysis of GATA1 mutations in Down syndrome transient myeloproliferative disorder and myeloid leukemia. Blood 118, 2222–2238 (2011).
  CAS PubMed Google Scholar
• Kanezaki, R. et al. Down syndrome and GATA1 mutations in transient abnormal myeloproliferative disorder: mutation classes correlate with progression to myeloid leukemia. Blood 116, 4631–4638 (2010).
  CAS PubMed Google Scholar
• Zipursky, A. Transient leukaemia—a benign form of leukaemia in newborn infants with trisomy 21. Br. J. Haematol. 120, 930–938 (2003).
  PubMed Google Scholar
• Muramatsu, H. et al. Risk factors for early death in neonates with Down syndrome and transient leukaemia. Br. J. Haematol. 142, 610–615 (2008).
  PubMed Google Scholar
• Roy, A. et al. Perturbation of fetal liver hematopoietic stem and progenitor cell development by trisomy 21. Proc. Natl Acad. Sci. USA 109, 17579–17584 (2012).
  CAS PubMed PubMed Central Google Scholar
• Woo, A. J. et al. Developmental differences in IFN signaling affect GATA1s-induced megakaryocyte hyperproliferation. J. Clin. Invest. 123, 3292–3304 (2013).
  CAS PubMed Central Google Scholar
• Nikolaev, S. I. et al. Exome sequencing identifies putative drivers of progression of transient myeloproliferative disorder to AMKL in infants with Down syndrome. Blood 122, 554–561 (2013).
  CAS PubMed Google Scholar
• Saida, S. et al. Clonal selection in xenografted TAM recapitulates the evolutionary process of myeloid leukemia in Down syndrome. Blood 121, 4377–4387 (2013).
  CAS PubMed Google Scholar
• Roberts, I. et al. GATA1-mutant clones are frequent and often unsuspected in babies with Down syndrome: identification of a population at risk of leukemia. Blood 122, 3908–3917 (2013).
  CAS PubMed PubMed Central Google Scholar
• Ford, A. M. et al. In utero rearrangements in the trithorax-related oncogene in infant leukaemias. Nature 363, 358–360 (1993).
  CAS PubMed Google Scholar
• Wiemels, J. L. et al. Prenatal origin of acute lymphoblastic leukaemia in children. Lancet 354, 1499–1503 (1999).
  CAS PubMed Google Scholar
• Teuffel, O. et al. Prenatal origin of separate evolution of leukemia in identical twins. Leukemia 18, 1624–1629 (2004).
  CAS PubMed Google Scholar
• Taub, J. W. et al. High frequency of leukemic clones in newborn screening blood samples of children with B-precursor acute lymphoblastic leukemia. Blood 99, 2992–2996 (2002).
  CAS PubMed Google Scholar
• Eguchi-Ishimae, M. et al. Breakage and fusion of the TEL (ETV6) gene in immature B lymphocytes induced by apoptogenic signals. Blood 97, 737–743 (2001).
  CAS PubMed Google Scholar
• McHale, C. M. et al. Prenatal origin of ETV6–RUNX1-positive acute lymphoblastic leukemia in children born in California. Genes Chromosomes Cancer 37, 36–43 (2003).
  CAS PubMed Google Scholar
• Olsen, M. et al. Preleukemic TEL–AML1-positive clones at cell level of 10(−3) to 10(−4) do not persist into adulthood. J. Pediatr. Hematol.Oncol. 28, 734–740 (2006).
  CAS PubMed Google Scholar
• Hong, D. et al. Initiating and cancer-propagating cells in TEL–AML1-associated childhood leukemia. Science 319, 336–339 (2008).
  CAS PubMed Google Scholar
• Tuszuki, S. & Seto, M. TEL (ETV6)-AML1 (RUNX1) initiates self-renewing fetal pro-B cells in association with a transcriptional program shared with embryonic stem cells in mice. Stem Cells 31, 236–247 (2013).
  Google Scholar
• Torrano, V., Procter, J., Cardus, P., Greaves, M. & Ford, A. M. ETV6-RUNX1 promotes survival of early B lineage progenitor cells via a dysregulated erythropoietin receptor. Blood 118, 4910–4918 (2011).
  CAS PubMed Google Scholar
• van der Weyden, L. et al. Modeling the evolution of ETV6-RUNX1-induced B-cell precursor acute lymphoblastic leukemia in mice. Blood 118, 1041–1051 (2011).
  CAS PubMed Google Scholar
• Ford, A. M. et al. The TEL–AML1 leukemia fusion gene dysregulates the TGF-β pathway in early B lineage progenitor cells. J. Clin. Invest. 119, 826–836 (2009).
  CAS PubMed PubMed Central Google Scholar
• Cazzaniga, G. et al. Developmental origins and impact of BCR-ABL1 fusion and IKZF1 deletions in monozygotic twins with Ph+ acute lymphoblastic leukemia. Blood 118, 5559–5564 (2011).
  CAS PubMed PubMed Central Google Scholar
• Chuk, M. K., McIntyre, E., Small, D. & Brown, P. Discordance of MLL-rearranged (MLL-R) infant acute lymphoblastic leukemia in monozygotic twins with spontaneous clearance of preleukemic clone in unaffected twin. Blood 113, 6691–6694 (2009).
  CAS PubMed PubMed Central Google Scholar
• Powell, B. C. et al. Identification of TP53 as an acute lymphocytic leukemia susceptibility gene through exome sequencing. Pediatr. Blood Cancer 60, E1–E3 (2013).
  CAS PubMed Google Scholar
• Holmfeldt, L. et al. The genomic landscape of hypodiploid acute lymphoblastic leukemia. Nature Genet. 45, 242–252 (2013).
  CAS PubMed Google Scholar
• Ito, M. Control of mental activities by internal models in the cerebellum. Nature Rev. Neurosci. 9, 304–313 (2008).
  CAS Google Scholar
• Simeone, A., Acampora, D., Gulisano, M., Stornaiuolo, A. & Boncinelli, E. Nested expression domains of four homeobox genes in developing rostral brain. Nature 358, 687–690 (1992).
  CAS PubMed Google Scholar
• Wingate, R. J. & Hatten, M. E. The role of the rhombic lip in avian cerebellum development. Development 126, 4395–4404 (1999).
  CAS PubMed Google Scholar
• Adamson, D. C. et al. OTX2 is critical for the maintenance and progression of Shh-independent medulloblastomas. Cancer Res. 70, 181–191 (2010).
  CAS PubMed Google Scholar
• Bai, R. Y., Staedtke, V., Lidov, H. G., Eberhart, C. G. & Riggins, G. J. OTX2 represses myogenic and neuronal differentiation in medulloblastoma cells. Cancer Res. 72, 5988–6001 (2012).
  CAS PubMed PubMed Central Google Scholar
• Bunt, J. et al. OTX2 directly activates cell cycle genes and inhibits differentiation in medulloblastoma cells. Int. J. Cancer 131, E21–E32 (2012).
  CAS PubMed Google Scholar
• Hatten, M. E. & Heintz, N. Mechanisms of neural patterning and specification in the developing cerebellum. Annu. Rev. Neurosci. 18, 385–408 (1995).
  CAS PubMed Google Scholar
• Morales, D. & Hatten, M. E. Molecular markers of neuronal progenitors in the embryonic cerebellar anlage. J. Neurosci. 26, 12226–12236 (2006).
  CAS PubMed PubMed Central Google Scholar
• Spassky, N. et al. Primary cilia are required for cerebellar development and Shh-dependent expansion of progenitor pool. Dev. Biol. 317, 246–259 (2008).
  CAS PubMed PubMed Central Google Scholar
• Chang, C. H., Chang, F. M., Yu, C. H., Ko, H. C. & Chen, H. Y. Assessment of fetal cerebellar volume using three-dimensional ultrasound. Ultrasound Med. Biol. 26, 981–988 (2000).
  CAS PubMed Google Scholar
• Volpe, J. J. Cerebellum of the premature infant: rapidly developing, vulnerable, clinically important. J. Child Neurol. 24, 1085–1104 (2009).
  PubMed PubMed Central Google Scholar
• Andersen, B. B., Korbo, L. & Pakkenberg, B. A quantitative study of the human cerebellum with unbiased stereological techniques. J. Comparative Neurol. 326, 549–560 (1992).
  CAS Google Scholar
• Dahmane, N. & Ruiz i Altaba, A. Sonic hedgehog regulates the growth and patterning of the cerebellum. Development 126, 3089–3100 (1999).
  PubMed Google Scholar
• Lee, A. et al. Isolation of neural stem cells from the postnatal cerebellum. Nature Neurosci. 8, 723–729 (2005).
  CAS PubMed Google Scholar
• Wang, V. Y., Rose, M. F. & Zoghbi, H. Y. Math1 expression redefines the rhombic lip derivatives and reveals novel lineages within the brainstem and cerebellum. Neuron 48, 31–43 (2005).
  CAS PubMed Google Scholar
• Raaf, J. & Kernohan, J. W. A study of the external granular layer in the cerebellum. The disappearance of the external granular layer and the growth of the molecular and internal granular layers in the cerebellum. Am. J. Anat. 75, 151–172 (1944).
  Google Scholar
• Gailani, M. R. et al. Developmental defects in Gorlin syndrome related to a putative tumor suppressor gene on chromosome 9. Cell 69, 111–117 (1992).
  CAS PubMed Google Scholar
• Hahn, H. et al. Mutations of the human homolog of Drosophila patched in the nevoid basal cell carcinoma syndrome. Cell 85, 841–851 (1996).
  CAS PubMed Google Scholar
• Northcott, P. A. et al. Medulloblastoma comprises four distinct molecular variants. J. Clin. Oncol. 29, 1408–1414 (2011).
  PubMed Google Scholar
• Goodrich, L. V., Milenkovic, L., Higgins, K. M. & Scott, M. P. Altered neural cell fates and medulloblastoma in mouse patched mutants. Science 277, 1109–1113 (1997).
  CAS PubMed Google Scholar
• Brugieres, L. et al. Incomplete penetrance of the predisposition to medulloblastoma associated with germ-line SUFU mutations. J. Med. Genet. 47, 142–144 (2010).
  CAS PubMed Google Scholar
• Northcott, P. A. et al. Subgroup-specific structural variation across 1,000 medulloblastoma genomes. Nature 488, 49–56 (2012).
  CAS PubMed PubMed Central Google Scholar
• Thomas, W. D. et al. Patched1 deletion increases N-Myc protein stability as a mechanism of medulloblastoma initiation and progression. Oncogene 28, 1605–1615 (2009).
  CAS PubMed Google Scholar
• Hallahan, A. R. et al. The SmoA1 mouse model reveals that Notch signaling is critical for the growth and survival of sonic hedgehog-induced medulloblastomas. Cancer Res. 64, 7794–7800 (2004).
  CAS PubMed Google Scholar
• Mao, J. et al. A novel somatic mouse model to survey tumorigenic potential applied to the Hedgehog pathway. Cancer Res. 66, 10171–10178 (2006).
  CAS PubMed PubMed Central Google Scholar
• Weiner, H. L. et al. Induction of medulloblastomas in mice by sonic hedgehog, independent of Gli1. Cancer Res. 62, 6385–6389 (2002).
  CAS PubMed Google Scholar
• Schuller, U. et al. Acquisition of granule neuron precursor identity is a critical determinant of progenitor cell competence to form Shh-induced medulloblastoma. Cancer Cell 14, 123–134 (2008).
  CAS PubMed PubMed Central Google Scholar
• Yang, Z. J. et al. Medulloblastoma can be initiated by deletion of Patched in lineage-restricted progenitors or stem cells. Cancer Cell 14, 135–145 (2008).
  CAS PubMed PubMed Central Google Scholar
• Knoepfler, P. S., Cheng, P. F. & Eisenman, R. N. N-myc is essential during neurogenesis for the rapid expansion of progenitor cell populations and the inhibition of neuronal differentiation. Genes Dev. 16, 2699–2712 (2002).
  CAS PubMed PubMed Central Google Scholar
• Browd, S. R. et al. N-myc can substitute for insulin-like growth factor signaling in a mouse model of sonic hedgehog-induced medulloblastoma. Cancer Res. 66, 2666–2672 (2006).
  CAS PubMed Google Scholar
• Korshunov, A. et al. Biological and clinical heterogeneity of _MYCN_-amplified medulloblastoma. Acta Neuropathol. 123, 515–527 (2012).
  CAS PubMed Google Scholar
• Swartling, F. J. et al. Pleiotropic role for MYCN in medulloblastoma. Genes Dev. 24, 1059–1072 (2010).
  CAS PubMed PubMed Central Google Scholar
• Kawauchi, D. et al. A mouse model of the most aggressive subgroup of human medulloblastoma. Cancer Cell 21, 168–180 (2012).
  CAS PubMed PubMed Central Google Scholar
• Pei, Y. et al. An animal model of MYC-driven medulloblastoma. Cancer Cell 21, 155–167 (2012).
  CAS PubMed PubMed Central Google Scholar
• Kool, M. et al. Molecular subgroups of medulloblastoma: an international meta-analysis of transcriptome, genetic aberrations, and clinical data of WNT, SHH, Group 3, and Group 4 medulloblastomas. Acta Neuropathol. 123, 473–484 (2012).
  CAS PubMed PubMed Central Google Scholar
• Pei, Y. et al. WNT signaling increases proliferation and impairs differentiation of stem cells in the developing cerebellum. Development 139, 1724–1733 (2012).
  CAS PubMed PubMed Central Google Scholar
• Kropilak, M., Jagelman, D. G., Fazio, V. W., Lavery, I. L. & McGannon, E. Brain tumors in familial adenomatous polyposis. Diseases Colon Rectum 32, 778–782 (1989).
  CAS Google Scholar
• Taylor, M. D. et al. Failure of a medulloblastoma-derived mutant of SUFU to suppress WNT signaling. Oncogene 23, 4577–4583 (2004).
  CAS PubMed Google Scholar
• Robinson, G. et al. Novel mutations target distinct subgroups of medulloblastoma. Nature 488, 43–48 (2012).
  CAS PubMed PubMed Central Google Scholar
• Barker, N. et al. The chromatin remodelling factor Brg-1 interacts with β-catenin to promote target gene activation. EMBO J. 20, 4935–4943 (2001).
  CAS PubMed PubMed Central Google Scholar
• Pugh, T. J. et al. Medulloblastoma exome sequencing uncovers subtype-specific somatic mutations. Nature 488, 106–110 (2012).
  CAS PubMed PubMed Central Google Scholar
• Momota, H., Shih, A. H., Edgar, M. A. & Holland, E. C. c-Myc and β-catenin cooperate with loss of p53 to generate multiple members of the primitive neuroectodermal tumor family in mice. Oncogene 27, 4392–4401 (2008).
  CAS PubMed Google Scholar
• Gibson, P. et al. Subtypes of medulloblastoma have distinct developmental origins. Nature 468, 1095–1099 (2010).
  CAS PubMed PubMed Central Google Scholar
• Takebayashi, H. et al. Non-overlapping expression of Olig3 and Olig2 in the embryonic neural tube. Mech. Dev. 113, 169–174 (2002).
  CAS PubMed Google Scholar
• Taylor, M. D. et al. Molecular subgroups of medulloblastoma: the current consensus. Acta Neuropathol. 123, 465–472 (2012).
  CAS PubMed Google Scholar
• Swartling, F. J. et al. Distinct neural stem cell populations give rise to disparate brain tumors in response to N-MYC. Cancer Cell 21, 601–613 (2012).
  CAS PubMed PubMed Central Google Scholar
• Stehelin, D., Varmus, H. E., Bishop, J. M. & Vogt, P. K. DNA related to the transforming gene(s) of avian sarcoma viruses is present in normal avian DNA. Nature 260, 170–173 (1976).
  CAS PubMed Google Scholar
• Siddhartha, M. The Emperor of All Maladies: A Biography of Cancer (Scribner, 2010).
  Google Scholar
• Knudson, A. G. Jr Mutation and cancer: statistical study of retinoblastoma. Proc. Natl Acad. Sci. USA 68, 820–823 (1971).
  PubMed PubMed Central Google Scholar
• Stephens, P. J. et al. Massive genomic rearrangement acquired in a single catastrophic event during cancer development. Cell 144, 27–40 (2011).
  CAS PubMed PubMed Central Google Scholar
• Forment, J. V., Kaidi, A. & Jackson, S. P. Chromothripsis and cancer: causes and consequences of chromosome shattering. Nat. Rev. Cancer 12, 663–670 (2012).
  CAS PubMed Google Scholar
• Molenaar, J. J. et al. Sequencing of neuroblastoma identifies chromothripsis and defects in neuritogenesis genes. Nature 483, 589–593 (2012).
  CAS PubMed Google Scholar
• Otto, T. et al. Stabilization of N-Myc is a critical function of Aurora A in human neuroblastoma. Cancer Cell 15, 67–78 (2009).
  CAS PubMed Google Scholar
• Masciari, S. et al. F18-fluorodeoxyglucose-positron emission tomography/computed tomography screening in Li-Fraumeni syndrome. JAMA 299, 1315–1319 (2008).
  CAS PubMed Google Scholar
• Custodio, G. et al. Impact of neonatal screening and surveillance for the TP53 R337H mutation on early detection of childhood adrenocortical tumors. J. Clin. Oncol. 31, 2619–2626 (2013).
  PubMed PubMed Central Google Scholar
• Yoshimoto, M. et al. Embryonic day 9 yolk sac and intra-embryonic hemogenic endothelium independently generate a B-1 and marginal zone progenitor lacking B-2 potential. Proc. Natl Acad. Sci. USA 108, 1468–1473 (2011).
  CAS PubMed PubMed Central Google Scholar
• Hardy, R. R. B-1 B cell development. J. Immunol. 177, 2749–2754 (2006).
  CAS PubMed Google Scholar
• Montecino-Rodriguez, E. & Dorshkind, K. Formation of B-1 B cells from neonatal B-1 transitional cells exhibits NF-kB redundancy. J. Immunol. 187, 5712–5719 (2011).
  CAS PubMed Google Scholar
• Adolfsson, J. et al. Identification of Flt3+ lympho-myeloid stem cells lacking erythro-megakaryocytic potential a revised road map for adult blood lineage commitment. Cell 121, 295–306 (2005).
  CAS PubMed Google Scholar
• Li, Y. S., Wasserman, R., Hayakawa, K. & Hardy, R. R. Identification of the earliest B lineage stage in mouse bone marrow. Immunity 5, 527–535 (1996).
  CAS PubMed Google Scholar
• Rumfelt, L. L., Zhou, Y., Rowley, B. M., Shinton, S. A. & Hardy, R. R. Lineage specification and plasticity in CD19− early B cell precursors. J. Exp. Med. 203, 675–687 (2006).
  CAS PubMed PubMed Central Google Scholar
• Sitnicka, E. et al. Complementary signaling through flt3 and interleukin-7 receptor α is indispensable for fetal and adult B cell genesis. J. Exp. Med. 198, 1495–1506 (2003).
  CAS PubMed PubMed Central Google Scholar
• Sitnicka, E. et al. Key role of flt3 ligand in regulation of the common lymphoid progenitor but not in maintenance of the hematopoietic stem cell pool. Immunity 17, 463–472 (2002).
  CAS PubMed Google Scholar
• Nutt, S. L. & Kee, B. L. The transcriptional regulation of B cell lineage commitment. Immunity 26, 715–725 (2007).
  CAS PubMed Google Scholar
• Kirstetter, P., Thomas, M., Dierich, A., Kastner, P. & Chan, S. Ikaros is critical for B cell differentiation and function. Eur. J. Immunol. 32, 720–730 (2002).
  CAS PubMed Google Scholar
• Wang, J. H. et al. Selective defects in the development of the fetal and adult lymphoid system in mice with an Ikaros null mutation. Immunity 5, 537–549 (1996).
  CAS PubMed Google Scholar
• Yoshida, T., Ng, S. Y., Zuniga-Pflucker, J. C. & Georgopoulos, K. Early hematopoietic lineage restrictions directed by Ikaros. Nature Immunol. 7, 382–391 (2006).
  CAS Google Scholar
• Mullighan, C. G. et al. BCR-ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros. Nature 453, 110–114 (2008).
  CAS PubMed Google Scholar
• Cobaleda, C., Jochum, W. & Busslinger, M. Conversion of mature B cells into T cells by dedifferentiation to uncommitted progenitors. Nature 449, 473–477 (2007).
  CAS PubMed Google Scholar
• Mullighan, C. G. et al. Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia. Nature 446, 758–764 (2007).
  CAS PubMed Google Scholar
• Shah, S. et al. A recurrent germline PAX5 mutation confers susceptibility to pre-B cell acute lymphoblastic leukemia. Nature Genet. 45, 1226–1231 (2013).
  CAS PubMed Google Scholar
• Bain, G. et al. Both E12 and E47 allow commitment to the B cell lineage. Immunity 6, 145–154 (1997).
  CAS PubMed Google Scholar
• Borghesi, L. et al. E47 is required for V(D)J recombinase activity in common lymphoid progenitors. J. Exp. Med. 202, 1669–1677 (2005).
  CAS PubMed PubMed Central Google Scholar
• Welinder, E. et al. The transcription factors E2A and HEB act in concert to induce the expression of FOXO1 in the common lymphoid progenitor. Proc. Natl Acad. Sci. USA 108, 17402–17407 (2011).
  CAS PubMed PubMed Central Google Scholar
• Kikuchi, K., Kasai, H., Watanabe, A., Lai, A. Y. & Kondo, M. IL-7 specifies B cell fate at the common lymphoid progenitor to pre-proB transition stage by maintaining early B cell factor expression. J. Immunol. 181, 383–392 (2008).
  CAS PubMed Google Scholar
• Seo, W., Ikawa, T., Kawamoto, H. & Taniuchi, I. Runx1-Cbfβ facilitates early B lymphocyte development by regulating expression of Ebf1. J. Exp. Med. 209, 1255–1262 (2012).
  CAS PubMed PubMed Central Google Scholar
• Growney, J. D. et al. Loss of Runx1 perturbs adult hematopoiesis and is associated with a myeloproliferative phenotype. Blood 106, 494–504 (2005).
  CAS PubMed PubMed Central Google Scholar
• Tsubono, Y. & Hisamichi, S. A halt to neuroblastoma screening in Japan. New Engl. J. Med. 350, 2010–2011 (2004).
  CAS PubMed Google Scholar
• Breslow, N., Olshan, A., Beckwith, J. B. & Green, D. M. Epidemiology of Wilms tumor. Med. Pediatr. Oncol. 21, 172–181 (1993).
  CAS PubMed Google Scholar
• Coppes, M. J., Haber, D. A. & Grundy, P. E. Genetic events in the development of Wilms' tumor. N. Engl. J. Med. 331, 586–590 (1994).
  CAS PubMed Google Scholar
• Park, S. et al. Inactivation of WT1 in nephrogenic rests, genetic precursors to Wilms' tumour. Nature Genet. 5, 363–367 (1993).
  CAS PubMed Google Scholar
• Chen, D. et al. Cell-specific effects of RB or RB/p107 loss on retinal development implicate an intrinsically death-resistant cell-of-origin in retinoblastoma. Cancer Cell 5, 539–551 (2004).
  CAS PubMed Google Scholar
• Zhang, J., Schweers, B. & Dyer, M. A. The first knockout mouse model of retinoblastoma. Cell Cycle 3, 952–959 (2004).
  CAS PubMed Google Scholar
• Federico, S., Brennan, R. & Dyer, M. A. Childhood cancer and developmental biology a crucial partnership. Curr. Top. Dev. Biol. 94, 1–13 (2011).
  CAS PubMed PubMed Central Google Scholar
• Abramson, D. H. et al. Rapid growth of retinoblastoma in a premature twin. Arch. Ophthalmol. 120, 1232–1233 (2002).
  PubMed Google Scholar
• Lohmann, D. R. & Gallie, B. L. Retinoblastoma: revisiting the model prototype of inherited cancer. Am. J. Med. Genet. C. Semin. Med. Genet. 129C, 23–28 (2004).
  PubMed Google Scholar
• Looijenga, L. H. & Oosterhuis, J. W. Pathogenesis of testicular germ cell tumours. Rev. Reprod. 4, 90–100 (1999).
  CAS PubMed Google Scholar
• Bussey, K. J. et al. Chromosome abnormalities of eighty-one pediatric germ cell tumors: sex-, age-, site-, and histopathology-related differences—a Children's Cancer Group study. Genes Chromosomes Cancer 25, 134–146 (1999).
  CAS PubMed Google Scholar
• Isaacs, H. Jr. Perinatal (fetal and neonatal) germ cell tumors. J. Pediatr. Surg. 39, 1003–1013 (2004).
  PubMed Google Scholar
• Schindler, J. W. et al. TEL–AML1 corrupts hematopoietic stem cells to persist in the bone marrow and initiate leukemia. Cell Stem Cell 5, 43–53 (2009).
  CAS PubMed Google Scholar
• Klochendler-Yeivin, A. et al. The murine SNF5/INI1 chromatin remodeling factor is essential for embryonic development and tumor suppression. EMBO Rep. 1, 500–506 (2000).
  CAS PubMed PubMed Central Google Scholar
• Versteege, I. et al. Truncating mutations of hSNF5/INI1 in aggressive paediatric cancer. Nature 394, 203–206 (1998).
  CAS PubMed Google Scholar
• Biegel, J. A. et al. Germ-line and acquired mutations of INI1 in atypical teratoid and rhabdoid tumors. Cancer Res. 59, 74–79 (1999).
  CAS PubMed Google Scholar
• Sevenet, N. et al. Constitutional mutations of the hSNF5/INI1 gene predispose to a variety of cancers. Am. J. Hum. Genet. 65, 1342–1348 (1999).
  CAS PubMed PubMed Central Google Scholar